Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vascular Surgery

Free Subscription Articles published in Catheter Cardiovasc Interv Retrieve available abstracts of 228 articles: HTML format Text format

Single Articles

October 2018
1. FABRIS E, Van't Hof A, Hamm CW, Lapostolle F, et al
   Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
   Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27921.
   PubMed     Text format     Abstract available
   
   
   November 2017
2. GOLDSTEIN JA
   Peri-procedural myocardial infarction: Plaques and patients "at-risk".
   Catheter Cardiovasc Interv. 2017;90:915-916.
   PubMed     Text format     Abstract available
   
   
   August 2017
3. GARCIA LA, Rocha-Singh KJ, Krishnan P, Zeller T, et al
   Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system.
   Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27198.
   PubMed     Text format     Abstract available
   
   
   
4. KAR S
   Transulnar cardiac catheterization and percutaneous coronary intervention: techniques, transradial comparisons, anatomical considerations, and comprehensive literature review.
   Catheter Cardiovasc Interv. 2017 Aug 2. doi: 10.1002/ccd.27220.
   PubMed     Text format     Abstract available
   
   
   
5. AGRAWAL M, Hakeem A, Ahmed Z, Uretsky BF, et al
   Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study.
   Catheter Cardiovasc Interv. 2017;90:225-232.
   PubMed     Text format     Abstract available
   
   
   July 2017
6. MANGELS DR, Giri J, Hirshfeld J, Wilensky RL, et al
   Robotic-assisted percutaneous coronary intervention.
   Catheter Cardiovasc Interv. 2017 Jul 19. doi: 10.1002/ccd.27205.
   PubMed     Text format     Abstract available
   
   
   
7. MIGLIORINI A, Valenti R, Vergara R, Grazia De Gregorio M, et al
   Angiographic and clinical outcome after crush of everolimus-eluting stent for distal unprotected left main disease.
   Catheter Cardiovasc Interv. 2017;90:72-77.
   PubMed     Text format     Abstract available
   
   
   June 2017
8. VIEIRA DE MELO RM, Hueb W, Nomura CH, Ribeiro da Silva EE, et al
   Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
   Catheter Cardiovasc Interv. 2017 Jun 2. doi: 10.1002/ccd.27125.
   PubMed     Text format     Abstract available
   
   
   
9. GARCIA LA, Rosenfield KR, Metzger CD, Zidar F, et al
   SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.
   Catheter Cardiovasc Interv. 2017;89:1259-1267.
   PubMed     Text format     Abstract available
   
   
   
10. CARR SM, Lubbe DF, Huber PR
    Percutaneous transcatheter balloon dilatation and stenting to the inflow cannula stenosis of a left ventricular assist device.
    Catheter Cardiovasc Interv. 2017;89:1219-1223.
    PubMed     Text format     Abstract available
    
    
    
11. ROCHA-SINGH KJ, Beckman JA, Ansel G, Lyden SP, et al
    Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Catheter Cardiovasc Interv. 2017;89:1250-1256.
    PubMed     Text format     Abstract available
    
    
    
12. HUNG CS, Yeh CF, Lin MS, Chen YH, et al
    Impact of hospital volume on long-term neurological outcome in patients undergoing carotid artery stenting.
    Catheter Cardiovasc Interv. 2017;89:1242-1249.
    PubMed     Text format     Abstract available
    
    
    
13. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Text format     Abstract available
    
    
    May 2017
14. BRENER MI, Bush A, Miller JM, Hasan RK, et al
    Influence of radial versus femoral access site on coronary angiography and intervention outcomes: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 May 25. doi: 10.1002/ccd.27043.
    PubMed     Text format     Abstract available
    
    
    
15. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Text format     Abstract available
    
    
    
16. VERDOIA M, Barbieri L, Parodi G, Bellandi B, et al
    Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26967.
    PubMed     Text format     Abstract available
    
    
    
17. POWELL RJ, Jaff MR, Schroe H, Benko A, et al
    Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system.
    Catheter Cardiovasc Interv. 2017;89:1069-1077.
    PubMed     Text format     Abstract available
    
    
    
18. FOLEY TR, Cotter RP, Kokkinidis DG, Nguyen DD, et al
    Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Catheter Cardiovasc Interv. 2017;89:1078-1085.
    PubMed     Text format     Abstract available
    
    
    
19. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Text format     Abstract available
    
    
    
20. WERNER GS, Glaser P, Coenen A, Moehlis H, et al
    Reduction of radiation exposure during complex interventions for chronic total coronary occlusions: Implementing low dose radiation protocols without affecting procedural success rates.
    Catheter Cardiovasc Interv. 2017;89:1005-1012.
    PubMed     Text format     Abstract available
    
    
    
21. SHIRAI S, Hirano K, Kobayashi N
    New endovascular technique for thrombus in the non-stenting zone-the Grab a Clot and Hold ON "(GACHON) technique": Case report.
    Catheter Cardiovasc Interv. 2017;89:1087-1092.
    PubMed     Text format     Abstract available
    
    
    
22. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Text format     Abstract available
    
    
    
23. ANDRADE PB, Mattos LA, Rinaldi FS, Bienert IC, et al
    Comparison of a vascular closure device versus the radial approach to reduce access site complications in non-ST-segment elevation acute coronary syndrome patients: The angio-seal versus the radial approach in acute coronary syndrome trial.
    Catheter Cardiovasc Interv. 2017;89:976-982.
    PubMed     Text format     Abstract available
    
    
    April 2017
24. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available
    
    
    
25. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
    Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
    PubMed     Text format     Abstract available
    
    
    
26. PATEL A, Nazif T, Stone GW, Ali ZA, et al
    Intraluminal bioresorbable vascular scaffold dismantling with aneurysm formation leading to very late thrombosis.
    Catheter Cardiovasc Interv. 2017;89:876-879.
    PubMed     Text format     Abstract available
    
    
    
27. AZZALINI L, Dautov R, Ojeda S, Serra A, et al
    Long-term outcomes of rotational atherectomy for the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2017;89:820-828.
    PubMed     Text format     Abstract available
    
    
    
28. PALENA LM, Diaz-Sandoval LJ, Sultato E, Brigato C, et al
    Feasibility and 1-Year outcomes of subintimal revascularization with supera(R) stenting of long femoropopliteal occlusions in critical limb ischemia: The "Supersub" Study.
    Catheter Cardiovasc Interv. 2017;89:910-920.
    PubMed     Text format     Abstract available
    
    
    
29. LEE MS, Lee AC, Shlofmitz RA, Martinsen BJ, et al
    ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Catheter Cardiovasc Interv. 2017;89:841-848.
    PubMed     Text format     Abstract available
    
    
    
30. ORTEGA-PAZ L, Capodanno D, Giacchi G, Gori T, et al
    Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.
    Catheter Cardiovasc Interv. 2017;89:812-818.
    PubMed     Text format     Abstract available
    
    
    
31. HUDED CP, Youmans QR, Sweis RN, Ricciardi MJ, et al
    The impact of operator experience during institutional adoption of trans-radial cardiac catheterization.
    Catheter Cardiovasc Interv. 2017;89:860-865.
    PubMed     Text format     Abstract available
    
    
    
32. SAKAKURA K, Funayama H, Taniguchi Y, Tsurumaki Y, et al
    The incidence of slow flow after rotational atherectomy of calcified coronary arteries: A randomized study of low speed versus high speed.
    Catheter Cardiovasc Interv. 2017;89:832-840.
    PubMed     Text format     Abstract available
    
    
    
33. HABARA M, Tsuchikane E, Nasu K, Kinoshita Y, et al
    The first clinical experience with a novel directional coronary atherectomy catheter: Preliminary Japanese multicenter experience.
    Catheter Cardiovasc Interv. 2017;89:880-887.
    PubMed     Text format     Abstract available
    
    
    
34. DAUTOV R, Nguyen CM, Rinfret S
    Stent luxation: Possible complication of subadventitial stenting in coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2017;89:872-875.
    PubMed     Text format     Abstract available
    
    
    
35. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    PubMed     Text format     Abstract available
    
    
    
36. HILLEGASS WB
    The many radial access learning curves.
    Catheter Cardiovasc Interv. 2017;89:865-866.
    PubMed     Text format     Abstract available
    
    
    
37. BELARDI JA, Albertal M
    Overlapping bioresorbable scaffolds seems safe for now.
    Catheter Cardiovasc Interv. 2017;89:818-819.
    PubMed     Text format     Abstract available
    
    
    
38. ANSEL GM, Jaff MR
    The Italian stallions of CLI "value care" delivery.
    Catheter Cardiovasc Interv. 2017;89:921-922.
    PubMed     Text format     Abstract available
    
    
    March 2017
39. DIN JN, Snow TM, Rao SV, Klinke WP, et al
    Variation in practice and concordance with guideline criteria for length of stay after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 31. doi: 10.1002/ccd.26992.
    PubMed     Text format     Abstract available
    
    
    
40. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
    Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
    PubMed     Text format     Abstract available
    
    
    
41. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
    Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
    Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
    PubMed     Text format     Abstract available
    
    
    
42. SOLA M, Venkatesh K, Caughey M, Rayson R, et al
    Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26963.
    PubMed     Text format     Abstract available
    
    
    
43. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available
    
    
    
44. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
    The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
    PubMed     Text format     Abstract available
    
    
    
45. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available
    
    
    
46. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available
    
    
    
47. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
    One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
    PubMed     Text format     Abstract available
    
    
    
48. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Text format     Abstract available
    
    
    
49. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
    Ischemic postconditioning during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
    PubMed     Text format     Abstract available
    
    
    
50. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available
    
    
    
51. CHE W, Dong H, Jiang X, Peng M, et al
    Subclavian artery stenting for coronary-subclavian steal syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
52. JIA H, Hu S, Liu H, Zhu Y, et al
    Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
53. QI J, Li Y, Li J, Jing Q, et al
    Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
54. HU S, Wang C, Zhe C, Zhu Y, et al
    Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: An In Vivo Optical Coherence Tomography Study.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
55. HE C, Ma YL, Wang CS, Song Y, et al
    Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
56. GAO L, Wang Y, Liu Y, Cao F, et al
    Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
57. QIU M, Li Y, Li J, Xu K, et al
    Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
58. DONG H, Peng M, Jiang X, Che W, et al
    Endovascular therapy for Angio-sealTM -related acute limb ischemia: Perioperative and long-term results.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
59. WANG G, Wang H, Xu B, Yang Y, et al
    Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCEL2) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
60. XU B, Bettinger N, Guan C, Redfors B, et al
    Impact of completeness of revascularization in complex coronary artery disease as measured with the SYNTAX revascularization index: An SEEDS Substudy.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available
    
    
    
61. BLOOMER TL, El-Hayek GE, McDaniel MC, Sandvall BC, et al
    Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:754-760.
    PubMed     Text format     Abstract available
    
    
    
62. LATINI RA, Buccheri D, Cortese B
    First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Catheter Cardiovasc Interv. 2017;89:676-678.
    PubMed     Text format     Abstract available
    
    
    
63. BELARDI JA, Albertal M
    Non-cardiac surgery after PCI: Watch out for complex lesions.
    Catheter Cardiovasc Interv. 2017;89:627-628.
    PubMed     Text format    
    
    
    
64. AZZALINI L, Brilakis ES
    Ipsilateral vs. contralateral vs. no collateral (antegrade only) chronic total occlusion percutaneous coronary interventions: What is the right choice for your practice?
    Catheter Cardiovasc Interv. 2017;89:656-657.
    PubMed     Text format    
    
    
    
65. PALMERINI T
    Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete?
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format    
    
    
    February 2017
66. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Text format     Abstract available
    
    
    
67. BABUNASHVILI AM, Pancholy SB, Kartashov DS
    New technique for treatment of postcatheterization radial artery pseudoaneurysm.
    Catheter Cardiovasc Interv. 2017;89:393-398.
    PubMed     Text format     Abstract available
    
    
    
68. ORTIZ D, Singh M, Jahangir A, Allaqaband S, et al
    Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
    Catheter Cardiovasc Interv. 2017;89:408-413.
    PubMed     Text format     Abstract available
    
    
    
69. BUTERA G, Piazza L, Heles M
    PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure.
    Catheter Cardiovasc Interv. 2017;89:480-483.
    PubMed     Text format     Abstract available
    
    
    
70. HEE L, Terluk A, Thomas L, Hopkins A, et al
    Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Catheter Cardiovasc Interv. 2017;89:375-382.
    PubMed     Text format     Abstract available
    
    
    
71. ZAHR F, Cigarroa JE
    Revascularization after coronary artery bypass grafting; Another episode in a long saga.
    Catheter Cardiovasc Interv. 2017;89:349-350.
    PubMed     Text format    
    
    
    
72. AZZALINI L, Jolicoeur EM
    The wise radialist's guide to optimal transfemoral access: Selection, performance, and troubleshooting.
    Catheter Cardiovasc Interv. 2017;89:399-407.
    PubMed     Text format     Abstract available
    
    
    
73. ZHANG D, Li Y, Yin D, He Y, et al
    Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26939.
    PubMed     Text format     Abstract available
    
    
    
74. LUZ A, Silveira I, Brochado B, Rodrigues P, et al
    Manual thrombectomy efficiency in relationship to the area at risk in patients with myocardial infarction with TIMI 0-1 coronary flow: Insights from an all comers registry.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26959.
    PubMed     Text format     Abstract available
    
    
    
75. SOUZA CF, Maehara A, Mintz GS, Matsumura M, et al
    Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26954.
    PubMed     Text format     Abstract available
    
    
    
76. RAVAT H, Garekar S, Changela V
    Left main coronary angioplasty of a 9-year-old child with bioresorable vascular scaffold.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26896.
    PubMed     Text format     Abstract available
    
    
    
77. DEHARO P, Strange JW, Mozid A
    Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26905.
    PubMed     Text format     Abstract available
    
    
    
78. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available
    
    
    
79. POTERUCHA JT, Taggart NW, Johnson JN, Cannon BC, et al
    Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Catheter Cardiovasc Interv. 2017;89:306-314.
    PubMed     Text format     Abstract available
    
    
    
80. KLEIN LW, Harjai KJ, Resnic F, Weintraub WS, et al
    2016 Revision of the SCAI position statement on public reporting.
    Catheter Cardiovasc Interv. 2017;89:269-279.
    PubMed     Text format    
    
    
    
81. VAN DEN HOVEN AT, Duijnhouwer AL, Eicken A, Aboulhosn J, et al
    Adverse outcome of coarctation stenting in patients with Turner syndrome.
    Catheter Cardiovasc Interv. 2017;89:280-287.
    PubMed     Text format     Abstract available
    
    
    
82. LIGON RA, Petit CJ
    Not that atretic: Use of an atretic femoral vein for transcatheter pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2017;89:321-323.
    PubMed     Text format     Abstract available
    
    
    
83. GARBO R, Oreglia JA, Gasparini GL
    The Balloon-Microcatheter technique for treatment of coronary artery perforations.
    Catheter Cardiovasc Interv. 2017;89:E75-E83.
    PubMed     Text format     Abstract available
    
    
    
84. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Text format     Abstract available
    
    
    
85. SAWAYA FJ, Morice MC, Spaziano M, Mehran R, et al
    Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.
    Catheter Cardiovasc Interv. 2017;89:178-189.
    PubMed     Text format     Abstract available
    
    
    
86. SHEMISA K, Karatasakis A, Brilakis ES
    Management of guidewire-induced distal coronary perforation using autologous fat particles versus coil embolization.
    Catheter Cardiovasc Interv. 2017;89:253-258.
    PubMed     Text format     Abstract available
    
    
    
87. PARSH J, Seth M, Green J, Sutton NR, et al
    Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26917.
    PubMed     Text format     Abstract available
    
    
    January 2017
88. CHATTERJEE S, Kundu A, Mukherjee D, Sardar P, et al
    Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26928.
    PubMed     Text format     Abstract available
    
    
    
89. GUAN C, Xu B, Qiao S, Qin L, et al
    Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26918.
    PubMed     Text format     Abstract available
    
    
    
90. TENEKECIOGLU E, Albuquerque FN, Sotomi Y, Zeng Y, et al
    Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26920.
    PubMed     Text format     Abstract available
    
    
    
91. BROWN ED, Blankenship JC
    A mechanism for stroke complicating thrombus aspiration.
    Catheter Cardiovasc Interv. 2017;89:93-96.
    PubMed     Text format     Abstract available
    
    
    
92. XHEPA E, Tada T, Kufner S, Ndrepepa G, et al
    Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
    Catheter Cardiovasc Interv. 2017;89:1-10.
    PubMed     Text format     Abstract available
    
    
    
93. KAWAMOTO H, Takagi K, Chieffo A, Ruparelia N, et al
    Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2017;89:13-24.
    PubMed     Text format     Abstract available
    
    
    
94. NAGANUMA T, Colombo A, Lesiak M, Capodanno D, et al
    Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Catheter Cardiovasc Interv. 2017;89:47-56.
    PubMed     Text format     Abstract available
    
    
    
95. BOUDJEMLINE Y
    Covidien micro vascular plug in congenital heart diseases and vascular anomalies: A new kid on the block for premature babies and older patients.
    Catheter Cardiovasc Interv. 2017;89:114-119.
    PubMed     Text format     Abstract available
    
    
    
96. FERRARO G, Marini D, Agnoletti G
    Off-label use of the amplatzer ductal occluder II additional size for percutaneous treatment of acute aortic occlusion in a baby.
    Catheter Cardiovasc Interv. 2017;89:E26-E29.
    PubMed     Text format     Abstract available
    
    
    
97. BUTERA G, Lovin N, Basile DP
    How to deal with atrial septal defect closure from right internal jugular vein: Role of venous-arterial circuit for sizing and over-the-wire device implantation.
    Catheter Cardiovasc Interv. 2017;89:120-123.
    PubMed     Text format     Abstract available
    
    
    
98. URIBE CE, Zuniga M, Madrid C
    Mechanical thrombectomy using the Solitaire stent in a left main coronary artery: A novel approach to coronary thrombus retrieval.
    Catheter Cardiovasc Interv. 2017;89:71-77.
    PubMed     Text format     Abstract available
    
    
    
99. BELARDI JA, Albertal M
    Double-stenting in distal left main lesions: Let's crush.
    Catheter Cardiovasc Interv. 2017;89:24-25.
    PubMed     Text format     Abstract available
    
    
    
100. CHATTERJEE A, Hillegass WB
     Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
     Catheter Cardiovasc Interv. 2017;89:11-12.
     PubMed     Text format     Abstract available
     
     
     December 2016
101. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
     Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
     Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
     PubMed     Text format     Abstract available
     
     
     
102. DING L, Pockett C, Moore J, El-Said H, et al
     Long sheath use in femoral artery catheterizations in infants <15 kg is associated with a higher thrombosis rate: Proposed Protocol for Detection and Management.
     Catheter Cardiovasc Interv. 2016;88:1108-1112.
     PubMed     Text format     Abstract available
     
     
     
103. KRAJCER Z, Ramaiah VG, Huetter M, Miller LE, et al
     Fast-track endovascular aortic repair: Interim report from the prospective LIFE registry.
     Catheter Cardiovasc Interv. 2016;88:1118-1123.
     PubMed     Text format     Abstract available
     
     
     
104. NGUYEN-TRONG PJ, Martinez Parachini JR, Resendes E, Karatasakis A, et al
     Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
     Catheter Cardiovasc Interv. 2016;88:1067-1074.
     PubMed     Text format     Abstract available
     
     
     
105. BOE BA, Rectenwald JE, Bocks ML
     Severely regurgitant left ventricle to ascending aorta conduit in a failing fontan patient treated with a vascular endograft and melody transcatheter pulmonary valve via hybrid approach.
     Catheter Cardiovasc Interv. 2016;88:1113-1117.
     PubMed     Text format     Abstract available
     
     
     
106. LYEN SM, Rodrigues JC, Manghat NE, Hamilton MC, et al
     Endovascular closure of thoracic aortic pseudoaneurysms: A combined device occlusion and coil embolization technique in patients unsuitable for surgery or stenting.
     Catheter Cardiovasc Interv. 2016;88:1155-1169.
     PubMed     Text format     Abstract available
     
     
     
107. SEGREST JH, Hillegass WB
     Radial Access Optimization in the Nascent Post-Adoption Era.
     Catheter Cardiovasc Interv. 2016;88:1044-1045.
     PubMed     Text format     Abstract available
     
     
     
108. BROWN BJ, Abbott JD
     A helping hand: GuideLiner use to facilitate stent delivery.
     Catheter Cardiovasc Interv. 2016;88:1065-1066.
     PubMed     Text format     Abstract available
     
     
     November 2016
109. SHARKAWI MA, Filippaios A, Dani SS, Shah SP, et al
     Identifying patients for safe early hospital discharge following st elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26873.
     PubMed     Text format     Abstract available
     
     
     
110. DANEK BA, Brilakis ES
     Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
     Catheter Cardiovasc Interv. 2016;88:897-898.
     PubMed     Text format    
     
     
     
111. SAFIAN RD
     Provisional rotablator for calcified lesions: The Russian roulette of PCI.
     Catheter Cardiovasc Interv. 2016;88:889-890.
     PubMed     Text format    
     
     
     
112. REILLY J
     You can't get there from here.
     Catheter Cardiovasc Interv. 2016;88:932-933.
     PubMed     Text format    
     
     
     
113. LEESAR MA
     Bioresorbable vascular scaffolds in coronary bifurcation lesions: The next frontiers?
     Catheter Cardiovasc Interv. 2016;88:870-871.
     PubMed     Text format    
     
     
     
114. HERBERT CE, Veeram Reddy S, Welch TR, Wang J, et al
     Bench and initial preclinical results of a novel 8 mm diameter double opposed helical biodegradable stent.
     Catheter Cardiovasc Interv. 2016;88:902-911.
     PubMed     Text format     Abstract available
     
     
     
115. RUZSA Z, Toth K, Nemes B, Edes IF, et al
     Transradial and transulnar access for iliac artery interventions using sheathless guiding systems: A feasibility study.
     Catheter Cardiovasc Interv. 2016;88:923-931.
     PubMed     Text format     Abstract available
     
     
     
116. TANAKA A, Jabbour RJ, Kawamoto H, Mangieri A, et al
     Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
     Catheter Cardiovasc Interv. 2016;88:865-870.
     PubMed     Text format     Abstract available
     
     
     
117. TANAKA A, Latib A, Kawamoto H, Jabbour RJ, et al
     Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
     Catheter Cardiovasc Interv. 2016;88:854-862.
     PubMed     Text format     Abstract available
     
     
     
118. TROBS M, Achenbach S, Rother J, Klinghammer L, et al
     Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
     Catheter Cardiovasc Interv. 2016;88:872-880.
     PubMed     Text format     Abstract available
     
     
     
119. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
     Rotational atherectomy in very long lesions: Results for the ROTATE registry.
     Catheter Cardiovasc Interv. 2016;88:E164-E172.
     PubMed     Text format     Abstract available
     
     
     
120. KOIFMAN E, Gaglia MA Jr, Escarcega RO, Bernardo NL, et al
     Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26669.
     PubMed     Text format     Abstract available
     
     
     
121. ASHER E, Mansour J, Wheeler A, Kendrick D, et al
     Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26835.
     PubMed     Text format     Abstract available
     
     
     
122. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
     Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
     PubMed     Text format     Abstract available
     
     
     
123. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
     Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
     PubMed     Text format     Abstract available
     
     
     
124. SHAH R, Matin K, Rogers KC, Rao SV, et al
     Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
     PubMed     Text format     Abstract available
     
     
     
125. SAFIAN RD
     Carotid artery stenting: Avoiding the perfect storm.
     Catheter Cardiovasc Interv. 2016;88:830-831.
     PubMed     Text format    
     
     
     
126. BLANKENSHIP JC
     Thrombus aspiration: Suck it up and keep looking for a niche.
     Catheter Cardiovasc Interv. 2016;88:725-726.
     PubMed     Text format    
     
     
     
127. SETO AH, Kern MJ
     Does the AToMIC trial explode concerns of contrast coagulopathy?
     Catheter Cardiovasc Interv. 2016;88:738-739.
     PubMed     Text format    
     
     
     
128. MCELHINNEY DB
     Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
     Catheter Cardiovasc Interv. 2016;88:811-813.
     PubMed     Text format    
     
     
     
129. FARHAN S, Mehran R
     STEMI with multivessel disease: An ongoing battle for the optimal treatment strategy.
     Catheter Cardiovasc Interv. 2016;88:707-708.
     PubMed     Text format    
     
     
     
130. ECHEVERRIA A, Krajcer Z
     Long-term outcomes of the SMART stent in femoro-popliteal disease in TASC A/B lesions and TASC C/D lesions.
     Catheter Cardiovasc Interv. 2016;88:841-842.
     PubMed     Text format    
     
     
     
131. BUTMAN SM
     The newly occluded ectatic vessel: Not an ecstatic time.
     Catheter Cardiovasc Interv. 2016;88:753-754.
     PubMed     Text format    
     
     
     
132. SHARMA R, Henry TD
     Come one, come all...the sooner the better!
     Catheter Cardiovasc Interv. 2016;88:689-690.
     PubMed     Text format    
     
     
     
133. RIZIK DG, Hermiller JB, Kereiakes DJ
     Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
     Catheter Cardiovasc Interv. 2016;88.
     PubMed     Text format     Abstract available
     
     
     
134. CHAMIE D, Garcia-Garcia H, Costa RA, Onuma Y, et al
     Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
     Catheter Cardiovasc Interv. 2016;88.
     PubMed     Text format     Abstract available
     
     
     
135. PERKINS LE, Kossuth MB, Fox JC, Rapoza RJ, et al
     Paving the way to a bioresorbable technology: Development of the absorb BRS program.
     Catheter Cardiovasc Interv. 2016;88.
     PubMed     Text format     Abstract available
     
     
     
136. TAMBURINO C, Capranzano P, Francaviglia B, Ina Tamburino C, et al
     Update on clinical evidence (Part II): A summary of the main post market studies.
     Catheter Cardiovasc Interv. 2016;88.
     PubMed     Text format     Abstract available
     
     
     
137. TANAKA A, Jabbour RJ, Latib A, Colombo A, et al
     Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
     Catheter Cardiovasc Interv. 2016;88.
     PubMed     Text format     Abstract available
     
     
     
138. ABIZAID A, Ribamar Costa J Jr
     The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology.
     Catheter Cardiovasc Interv. 2016;88.
     PubMed     Text format     Abstract available
     
     
     
139. BADINGS EA, Remkes WS, The SH, Dambrink JE, et al
     Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the ELISA-3 trial.
     Catheter Cardiovasc Interv. 2016;88:755-764.
     PubMed     Text format     Abstract available
     
     
     
140. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
     Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
     Catheter Cardiovasc Interv. 2016;88:804-810.
     PubMed     Text format     Abstract available
     
     
     
141. MATSUMI J, Tobita K, Shishido K, Mizuno S, et al
     Long-term outcomes of SMART stent implantation in patients with femoro-popliteal disease.
     Catheter Cardiovasc Interv. 2016;88:832-841.
     PubMed     Text format     Abstract available
     
     
     
142. MELLER SM, Salim Al-Damluji M, Gutierrez A, Stilp E, et al
     Carotid stenting versus endarterectomy for the treatment of carotid artery stenosis: Contemporary results from a large single center study.
     Catheter Cardiovasc Interv. 2016;88:822-830.
     PubMed     Text format     Abstract available
     
     
     
143. THEODOROPOULOS K, Mennuni MG, Dangas GD, Meelu OA, et al
     Resistant in-stent restenosis in the drug eluting stent era.
     Catheter Cardiovasc Interv. 2016;88:777-785.
     PubMed     Text format     Abstract available
     
     
     October 2016
144. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
     Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
     Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
     PubMed     Text format     Abstract available
     
     
     
145. IELASI A, Varricchio A, Campo G, Leoncini M, et al
     A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.
     Catheter Cardiovasc Interv. 2016 Oct 24. doi: 10.1002/ccd.26801.
     PubMed     Text format     Abstract available
     
     
     
146. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
     Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
     Catheter Cardiovasc Interv. 2016;88:546-553.
     PubMed     Text format     Abstract available
     
     
     
147. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
     Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
     Catheter Cardiovasc Interv. 2016;88:508-514.
     PubMed     Text format     Abstract available
     
     
     
148. ARORA S, Panaich SS, Patel N, Patel NJ, et al
     Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006-2011).
     Catheter Cardiovasc Interv. 2016;88:605-616.
     PubMed     Text format     Abstract available
     
     
     
149. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
     Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
     Catheter Cardiovasc Interv. 2016;88:522-528.
     PubMed     Text format     Abstract available
     
     
     
150. TIAN W, Mahmoudi M, Lhermusier T, Kiramijyan S, et al
     The influence of advancing age on implantation of drug-eluting stents.
     Catheter Cardiovasc Interv. 2016;88:516-521.
     PubMed     Text format     Abstract available
     
     
     
151. SINGH S, Singh N, Gulati GS, Ramakrishnan S, et al
     Dual-Source Computed Tomography for Chronic Total Occlusion of Coronary Arteries.
     Catheter Cardiovasc Interv. 2016;88:E117-E125.
     PubMed     Text format     Abstract available
     
     
     
152. BELARDI JA, Albertal M
     Ischemic Postconditioning: Not Giving Up Yet.
     Catheter Cardiovasc Interv. 2016;88:514-515.
     PubMed     Text format     Abstract available
     
     
     
153. SAFIAN RD
     The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI.
     Catheter Cardiovasc Interv. 2016;88:506-507.
     PubMed     Text format    
     
     
     
154. HEUSER RR
     ACS Treatment Continues to Improve: But Price Matters.
     Catheter Cardiovasc Interv. 2016;88:544-545.
     PubMed     Text format     Abstract available
     
     
     September 2016
155. WANG H, Li Y, Cong H, Ding S, et al
     Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
     Catheter Cardiovasc Interv. 2016 Sep 28. doi: 10.1002/ccd.26804.
     PubMed     Text format     Abstract available
     
     
     
156. VERMA S, Burkhoff D, O'Neill WW
     Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
     Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26795.
     PubMed     Text format     Abstract available
     
     
     
157. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
     Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
     Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
     PubMed     Text format     Abstract available
     
     
     
158. SUKUL D, Seth M, Dixon SR, Zainea M, et al
     Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
     Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
     PubMed     Text format     Abstract available
     
     
     
159. A MCCROSSAN B, O'Callaghan B, P Walsh K
     Stent implantation to relieve native obstructed left partial anomalous pulmonary venous connections.
     Catheter Cardiovasc Interv. 2016;88:452-5.
     PubMed     Text format     Abstract available
     
     
     
160. DILETTI R, Tchetche D, Barbato E, Latib A, et al
     Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
     Catheter Cardiovasc Interv. 2016;88:397-406.
     PubMed     Text format     Abstract available
     
     
     
161. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
     Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
     Catheter Cardiovasc Interv. 2016;88:369-77.
     PubMed     Text format     Abstract available
     
     
     
162. MALEKZADEH-MILANI S, Jalal Z, Tamisier D, Boudjemline Y, et al
     Dilatable pulmonary artery band: Safety and efficacy of balloon dilatation.
     Catheter Cardiovasc Interv. 2016;88:446-51.
     PubMed     Text format     Abstract available
     
     
     
163. SOTOMI Y, Serruys PW
     Promising, but still a matter of debate.
     Catheter Cardiovasc Interv. 2016;88:378-9.
     PubMed     Text format     Abstract available
     
     
     
164. BELARDI JA, Albertal M
     To achieve, or not to achieve complete revascularization.
     Catheter Cardiovasc Interv. 2016;88:338-9.
     PubMed     Text format     Abstract available
     
     
     
165. GOLDSTEIN JA
     Stenting precision: "Image small, miss small".
     Catheter Cardiovasc Interv. 2016;88:348-9.
     PubMed     Text format     Abstract available
     
     
     
166. HEUSER RR
     Coronary perforation: The solution is right on the table.
     Catheter Cardiovasc Interv. 2016;88:494.
     PubMed     Text format    
     
     
     
167. GEORGE S, Cotton J, Wrigley B
     Rebuttal: Coronary perforation: The solution is right on the table.
     Catheter Cardiovasc Interv. 2016;88:495.
     PubMed     Text format    
     
     
     August 2016
168. KORABATHINA R, Levine JC, Coppola JT
     Innovative use of a guideliner catheter to assist in snare retrieval of an entrapped kinked guide catheter during transradial coronary intervention.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26774.
     PubMed     Text format     Abstract available
     
     
     
169. AMINIAN A, Iglesias JF, Van Mieghem C, Zuffi A, et al
     First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26773.
     PubMed     Text format     Abstract available
     
     
     
170. SETO AH, Tyler J, Suh WM, Harrison AT, et al
     Defining the common femoral artery: Insights from the femoral arterial access with ultrasound trial.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26727.
     PubMed     Text format     Abstract available
     
     
     
171. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
     Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
     PubMed     Text format     Abstract available
     
     
     
172. MOTTILLO S, Filion KB, Joseph L, Eisenberg MJ, et al
     Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.
     Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26652.
     PubMed     Text format     Abstract available
     
     
     
173. KAWAMOTO H, Ruparelia N, Latib A, Miyazaki T, et al
     Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
     Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26725.
     PubMed     Text format     Abstract available
     
     
     
174. ALEXANDER J, Yohannan T, Abutineh I, Agrawal V, et al
     Ultrasound-guided femoral arterial access in pediatric cardiac catheterizations: A prospective evaluation of the prevalence, risk factors, and mechanism for acute loss of arterial pulse.
     Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26702.
     PubMed     Text format     Abstract available
     
     
     
175. YANG X, Tamez H, Lai C, Ho K, et al
     Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.
     Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26688.
     PubMed     Text format     Abstract available
     
     
     
176. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
     Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
     Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
     PubMed     Text format     Abstract available
     
     
     
177. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
     Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
     Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
     PubMed     Text format     Abstract available
     
     
     
178. RHEUDE TA, Xhepa E, Byrne RA
     Markedly different tissue types on optical coherence tomography imaging in a patient with multiple lesion drug-eluting stent in-stent restenosis.
     Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26694.
     PubMed     Text format     Abstract available
     
     
     
179. MIKI K, Fujii K, Kawasaki D, Shibuya M, et al
     Impact of analysis interval size on the quality of optical frequency domain imaging assessments of stent implantation for lesions of the superficial femoral artery.
     Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26673.
     PubMed     Text format     Abstract available
     
     
     
180. MINGES KE, Herrin J, Fiorilli PN, Curtis JP, et al
     Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients.
     Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26701.
     PubMed     Text format     Abstract available
     
     
     
181. BRADLEY EA, Berman D, Daniels CJ
     First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy.
     Catheter Cardiovasc Interv. 2016;88:248-52.
     PubMed     Text format     Abstract available
     
     
     
182. NOONAN P, Kudumula V, Anderson B, Ramchandani B, et al
     Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome.
     Catheter Cardiovasc Interv. 2016;88:225-32.
     PubMed     Text format     Abstract available
     
     
     
183. VOGEL B, Mehran R
     Arterial hypertension: A neglected risk for bleeding.
     Catheter Cardiovasc Interv. 2016;88:191-2.
     PubMed     Text format     Abstract available
     
     
     
184. BELARDI JA, Albertal M
     Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues....
     Catheter Cardiovasc Interv. 2016;88:182-3.
     PubMed     Text format     Abstract available
     
     
     July 2016
185. ROSSINI R, Angiolillo DJ, Musumeci G, Capodanno D, et al
     Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
     Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26629.
     PubMed     Text format     Abstract available
     
     
     
186. MANOLY I, Hasan R, Brazier A, Farooq V, et al
     Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
     Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
     PubMed     Text format     Abstract available
     
     
     
187. COLLERAN R, Kufner S, Harada Y, Giacoppo D, et al
     Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.
     Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26597.
     PubMed     Text format     Abstract available
     
     
     
188. MASHAYEKHI K, Behnes M, Valuckiene Z, Bryniarski L, et al
     Comparison of the ipsi-lateral versus contra-lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions.
     Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26611.
     PubMed     Text format     Abstract available
     
     
     
189. SAFIAN RD
     Saphenous vein bypass graft intervention and embolic protection devices: Time for reassessment (and revision of percutaneous coronary intervention guidelines).
     Catheter Cardiovasc Interv. 2016;88:84-5.
     PubMed     Text format     Abstract available
     
     
     
190. COLLET C, Serruys PW
     Coronary bifurcations in clinical practice: Tell me what we can do better.
     Catheter Cardiovasc Interv. 2016;88:71-2.
     PubMed     Text format     Abstract available
     
     
     
191. BUTMAN SM
     In early returns scoring scores big.
     Catheter Cardiovasc Interv. 2016;88:60-1.
     PubMed     Text format     Abstract available
     
     
     
192. DANEK BA, Brilakis ES
     How to prevent and treat complications of the retrograde approach to chronic total occlusion percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2016;88:15-7.
     PubMed     Text format     Abstract available
     
     
     June 2016
193. CHATTERJEE S, Yeh RW, Sardar P, Ul Hassan Virk H, et al
     Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data.
     Catheter Cardiovasc Interv. 2016 Jun 24. doi: 10.1002/ccd.26643.
     PubMed     Text format     Abstract available
     
     
     
194. ARMSTRONG EJ, Graham L, Waldo SW, Valle JA, et al
     Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
     Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26624.
     PubMed     Text format     Abstract available
     
     
     
195. ELLWEIN L, Marks DS, Migrino RQ, Foley WD, et al
     Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.
     Catheter Cardiovasc Interv. 2016;87:1244-55.
     PubMed     Text format     Abstract available
     
     
     
196. SHISHEHBOR MH, Aronow HD, Bartholomew JR, Beckman JA, et al
     Vascular specialist response to medicare evidence development coverage advisory committee (MEDCAC) panel on peripheral artery disease of the lower extremities.
     Catheter Cardiovasc Interv. 2016;87:1181-6.
     PubMed     Text format    
     
     
     
197. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
     Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
     Catheter Cardiovasc Interv. 2016;87:1224-30.
     PubMed     Text format     Abstract available
     
     
     
198. QURESHI AM, Petit CJ, Crystal MA, Liou A, et al
     Efficacy and safety of catheter-based rheolytic and aspiration thrombectomy in children.
     Catheter Cardiovasc Interv. 2016;87:1273-80.
     PubMed     Text format     Abstract available
     
     
     
199. HIRA RS, Dean LS
     Fork in the road: Are all bifurcations created equal?
     Catheter Cardiovasc Interv. 2016;87:1242-3.
     PubMed     Text format     Abstract available
     
     
     
200. TOMMASO CL
     To aspirate or not!: The question may be not if, but when.
     Catheter Cardiovasc Interv. 2016;87:1211-2.
     PubMed     Text format     Abstract available
     
     
     
201. SARDAR MR, Dawn Abbott J
     Myocardial salvage and mortality in STEMI: A race against ischemic time.
     Catheter Cardiovasc Interv. 2016;87:1201-2.
     PubMed     Text format     Abstract available
     
     
     May 2016
202. FAZA NN, Mentias A, Parashar A, Chaudhury P, et al
     Bleeding Complications of Triple Antithrombotic Therapy after Percutaneous Coronary Interventions.
     Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26574.
     PubMed     Text format     Abstract available
     
     
     
203. JOSHI FR, Biasco L, Pedersen F, Holmvang L, et al
     Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
     Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26598.
     PubMed     Text format     Abstract available
     
     
     
204. MURAI T, Kanaji Y, Yonetsu T, Lee T, et al
     Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26596.
     PubMed     Text format     Abstract available
     
     
     
205. MAHMUD E, Dominguez A, Bahadorani J
     First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
     Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
     PubMed     Text format     Abstract available
     
     
     
206. BOCKSCH W, Grossmann B, Geisler T, Steeg M, et al
     Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
     Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26562.
     PubMed     Text format     Abstract available
     
     
     
207. KARATASAKIS A, Tarar MN, Karmpaliotis D, Alaswad K, et al
     Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry.
     Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26568.
     PubMed     Text format     Abstract available
     
     
     
208. CHANDRASEKHAR J, Baber U, Sartori S, Faggioni M, et al
     Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study.
     Catheter Cardiovasc Interv. 2016 May 6. doi: 10.1002/ccd.26606.
     PubMed     Text format     Abstract available
     
     
     
209. GONSKA B, Seeger J, Rodewald C, Scharnbeck D, et al
     Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
     Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26565.
     PubMed     Text format     Abstract available
     
     
     
210. IPEK G, Gungor B, Karatas MB, Onuk T, et al
     Risk factors and outcomes in patients with ectatic infarct-related artery who underwent primary percutaneous coronary intervention after ST elevated myocardial infarction.
     Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26553.
     PubMed     Text format     Abstract available
     
     
     
211. KAHLON TS, Barn K, Akram MM, Blankenship JC, et al
     Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
     Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26567.
     PubMed     Text format     Abstract available
     
     
     April 2016
212. O'NEILL BP, Wheatley G, Bashir R, Edmundowicz D, et al
     Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
     Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26530.
     PubMed     Text format     Abstract available
     
     
     
213. CARLINO M, Azzalini L, Colombo A
     A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26556.
     PubMed     Text format     Abstract available
     
     
     
214. ZAMAN S, Gooley R, Cheng V, McCormick L, et al
     Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
     Catheter Cardiovasc Interv. 2016 Apr 23. doi: 10.1002/ccd.26371.
     PubMed     Text format     Abstract available
     
     
     
215. TURNER ME, Addonizio LJ, Richmond ME, Zuckerman WA, et al
     Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
     Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26544.
     PubMed     Text format     Abstract available
     
     
     
216. LATINI RA, Granata F, Ielasi A, Varricchio A, et al
     Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
     Catheter Cardiovasc Interv. 2016 Apr 1. doi: 10.1002/ccd.26516.
     PubMed     Text format     Abstract available
     
     
     March 2016
217. SOLHPOUR A, Chang KW, Arain SA, Balan P, et al
     Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myo
     Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26523.
     PubMed     Text format     Abstract available
     
     
     
218. ADUSUMALLI S, Morris M, Pershad A
     Pseudo-Pericardial Tamponade From Right Ventricular Hematoma After Chronic Total Occlusion Percutaneous Coronary Intervention of the Right Coronary Artery: Successfully Managed Percutaneously With Computerized Tomographic Guided Drainage.
     Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26510.
     PubMed     Text format     Abstract available
     
     
     
219. STETLER J, Karatasakis A, Christakopoulos GE, Tarar MN, et al
     Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2016 Mar 25. doi: 10.1002/ccd.26505.
     PubMed     Text format     Abstract available
     
     
     
220. IKEDA N, Kubota S, Okazaki T, Hara H, et al
     Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
     Catheter Cardiovasc Interv. 2016 Mar 18. doi: 10.1002/ccd.26437.
     PubMed     Text format     Abstract available
     
     
     
221. PRASAD A, Ortiz-Lopez C, Khan A, Levin D, et al
     Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.
     Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26466.
     PubMed     Text format     Abstract available
     
     
     
222. MARKOVIC S, Lutzner M, Rottbauer W, Wohrle J, et al
     Zotarolimus compared with everolimus eluting stents-angiographic and clinical results after recanalization of true coronary chronic total occlusions.
     Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26482.
     PubMed     Text format     Abstract available
     
     
     
223. IQBAL MB, Nadra IJ, Ding L, Fung A, et al
     Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
     Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26479.
     PubMed     Text format     Abstract available
     
     
     February 2016
224. PHILIP F, Stewart S, Southard JA
     Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
     Catheter Cardiovasc Interv. 2016 Feb 24. doi: 10.1002/ccd.26458.
     PubMed     Text format     Abstract available
     
     
     
225. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
     Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
     Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
     PubMed     Text format     Abstract available
     
     
     
226. KHAN R, Al-Hawwas M, Hatem R, Azzalini L, et al
     Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
     Catheter Cardiovasc Interv. 2016 Feb 1. doi: 10.1002/ccd.26413.
     PubMed     Text format     Abstract available
     
     
     November 2015
227. LARMORE C, Effron MB, Molife C, DeKoven M, et al
     "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
     Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26279.
     PubMed     Text format     Abstract available
     
     
     
228. ELGENDY IY, Wen X, Mahmoud A, Bavry AA, et al
     Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials.
     Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26322.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: